Advertisement

Coronavirus Vaccine: 1,000 volunteers prepare for second dose of Covaxin

Follow The Hawk on Google News+ Follow

Advertisement

New Delhi: The first dose of indigenously developed coronavirus vaccine, Covaxin, has been successfully administered to 1,000 volunteers at Prakhar Hospital as part of phase III trial.

Dr JS Kushwaha, principal investigator at Prakhar hospital, said: "The second dose of Covaxin would also be administered to these 1,000 volunteers from January 3. First dose of this vaccine was given to volunteers from different walks of life."

Advertisement

The first group of volunteers was administered the vaccine on December 5, and thereafter, this drive continued till December 21.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

It took 17 days to administer Covaxin to these 1,000 volunteers.

Hyderabad-based Bharat Biotech is developing the country's indigenous Corona virus vaccine in collaboration with the Indian Council of Medical Research (ICMR).

Advertisement

Kushwaha said that the first dose of Covaxin was administered successfully to all the volunteers and there was no report of any reaction or health issue faced by them.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

He also mentioned that like many others, he, too, was waiting for Covaxin to get emergency approval from the Drug Controller General of India.

Meanwhile, the second phase trial of Russia's Sputnik V vaccine had also taken place in the city.

In the first week of December, 13 volunteers were administered Sputnik V at the city's GSVM Medical College.

–IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST